EcoDrugPlus

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSSTUG00000015808
Gene Symbol: LOC115200016
3 Cross references
198 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSSTUG00000039272
Gene Symbol: LOC115164623
3 Cross references
198 Possible Orthologues:

40s Ribosomal Protein S10

Ensembl ID : ENSSTUG00000033496
Gene Symbol: LOC115165814
3 Cross references
360 Possible Orthologues:

40s Ribosomal Protein S10-Like

Ensembl ID : ENSSTUG00000026057
Gene Symbol: LOC115151031
3 Cross references
363 Possible Orthologues:

40s Ribosomal Protein S10-Like

Ensembl ID : ENSSTUG00000038295
Gene Symbol: LOC115168143
3 Cross references
362 Possible Orthologues:

40s Ribosomal Protein S10-Like

Ensembl ID : ENSSTUG00000018394
Gene Symbol: LOC115207395
3 Cross references
363 Possible Orthologues:

40s Ribosomal Protein S12

Ensembl ID : ENSSTUG00000030601
Gene Symbol: LOC115175188
3 Cross references
289 Possible Orthologues:

40s Ribosomal Protein S13-Like

Ensembl ID : ENSSTUG00000021996
Gene Symbol: LOC115167093
3 Cross references
360 Possible Orthologues:

40s Ribosomal Protein S13-Like

Ensembl ID : ENSSTUG00000019449
Gene Symbol: LOC115203232
3 Cross references
360 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSSTUG00000042781
Gene Symbol: LOC115154895
3 Cross references
276 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSSTUG00000025947
Gene Symbol: LOC115204526
3 Cross references
277 Possible Orthologues:

40s Ribosomal Protein S15

Ensembl ID : ENSSTUG00000047316
Gene Symbol: LOC115169963
3 Cross references
329 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).